Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Cash from Investing Activities (2024 - 2025)

Hinge Health's Cash from Investing Activities history spans 2 years, with the latest figure at -$37.7 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 1110.53% year-over-year to -$37.7 million; the TTM value through Dec 2025 reached -$97.0 million, changed N/A, while the annual FY2025 figure was -$113.8 million, 721.25% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$37.7 million at Hinge Health, up from -$58.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.5 million in Q3 2024 and bottomed at -$58.8 million in Q3 2025.